Medication regimen complexity in ambulatory older adults with heart failure

Michael R Cobretti,1 Robert L Page II,2 Sunny A Linnebur,2 Kimberly M Deininger,1 Amrut V Ambardekar,3 JoAnn Lindenfeld,4 Christina L Aquilante1 1Department of Pharmaceutical Sciences, 2Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, A...

Full description

Bibliographic Details
Main Authors: Cobretti MR, Page RL 2nd, Linnebur SA, Deininger KM, Ambardekar AV, Lindenfeld J, Aquilante CL
Format: Article
Language:English
Published: Dove Medical Press 2017-04-01
Series:Clinical Interventions in Aging
Subjects:
Online Access:https://www.dovepress.com/medication-regimen-complexity-in-ambulatory-older-adults-with-heart-fa-peer-reviewed-article-CIA
_version_ 1818852384836681728
author Cobretti MR
Page RL 2nd
Linnebur SA
Deininger KM
Ambardekar AV
Lindenfeld J
Aquilante CL
author_facet Cobretti MR
Page RL 2nd
Linnebur SA
Deininger KM
Ambardekar AV
Lindenfeld J
Aquilante CL
author_sort Cobretti MR
collection DOAJ
description Michael R Cobretti,1 Robert L Page II,2 Sunny A Linnebur,2 Kimberly M Deininger,1 Amrut V Ambardekar,3 JoAnn Lindenfeld,4 Christina L Aquilante1 1Department of Pharmaceutical Sciences, 2Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, 3Division of Cardiology, School of Medicine, University of Colorado, Aurora, CO, 4Advanced Heart Failure and Cardiac Transplant Program, Vanderbilt Heart and Vascular Institute, Nashville, TN, USA Purpose: Heart failure prevalence is increasing in older adults, and polypharmacy is a major problem in this population. We compared medication regimen complexity using the validated patient-level Medication Regimen Complexity Index (pMRCI) tool in “young-old” (60–74 years) versus “old-old” (75–89 years) patients with heart failure. We also compared pMRCI between patients with ischemic cardiomyopathy (ISCM) versus nonischemic cardiomyopathy (NISCM).Patients and methods: Medication lists were retrospectively abstracted from the electronic medical records of ambulatory patients aged 60–89 years with heart failure. Medications were categorized into three types – heart failure prescription medications, other prescription medications, and over-the-counter (OTC) medications – and scored using the pMRCI tool.Results: The study evaluated 145 patients (n=80 young-old, n=65 old-old, n=85 ISCM, n=60 NISCM, mean age 73±7 years, 64% men, 81% Caucasian). Mean total pMRCI scores (32.1±14.4, range 3–84) and total medication counts (13.3±4.8, range 2–30) were high for the entire cohort, of which 72% of patients were taking eleven or more total medications. Total and subtype pMRCI scores and medication counts did not differ significantly between the young-old and old-old groups, with the exception of OTC medication pMRCI score (6.2±4 young-old versus 7.8±5.8 old-old, P=0.04). With regard to heart failure etiology, total pMRCI scores and medication counts were significantly higher in patients with ISCM versus NISCM (pMRCI score 34.5±15.2 versus 28.8±12.7, P=0.009; medication count 14.1±4.9 versus 12.2±4.5, P=0.008), which was largely driven by other prescription medications.Conclusion: Medication regimen complexity is high in older adults with heart failure, and differs based on heart failure etiology. Additional work is needed to address polypharmacy and to determine if medication regimen complexity influences adherence and clinical outcomes in this population. Keywords: medication complexity, heart failure, elderly, geriatric, aged
first_indexed 2024-12-19T07:20:04Z
format Article
id doaj.art-157d31d80674490698935edeee686ed0
institution Directory Open Access Journal
issn 1178-1998
language English
last_indexed 2024-12-19T07:20:04Z
publishDate 2017-04-01
publisher Dove Medical Press
record_format Article
series Clinical Interventions in Aging
spelling doaj.art-157d31d80674490698935edeee686ed02022-12-21T20:30:58ZengDove Medical PressClinical Interventions in Aging1178-19982017-04-01Volume 1267968632362Medication regimen complexity in ambulatory older adults with heart failureCobretti MRPage RL 2ndLinnebur SADeininger KMAmbardekar AVLindenfeld JAquilante CLMichael R Cobretti,1 Robert L Page II,2 Sunny A Linnebur,2 Kimberly M Deininger,1 Amrut V Ambardekar,3 JoAnn Lindenfeld,4 Christina L Aquilante1 1Department of Pharmaceutical Sciences, 2Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, 3Division of Cardiology, School of Medicine, University of Colorado, Aurora, CO, 4Advanced Heart Failure and Cardiac Transplant Program, Vanderbilt Heart and Vascular Institute, Nashville, TN, USA Purpose: Heart failure prevalence is increasing in older adults, and polypharmacy is a major problem in this population. We compared medication regimen complexity using the validated patient-level Medication Regimen Complexity Index (pMRCI) tool in “young-old” (60–74 years) versus “old-old” (75–89 years) patients with heart failure. We also compared pMRCI between patients with ischemic cardiomyopathy (ISCM) versus nonischemic cardiomyopathy (NISCM).Patients and methods: Medication lists were retrospectively abstracted from the electronic medical records of ambulatory patients aged 60–89 years with heart failure. Medications were categorized into three types – heart failure prescription medications, other prescription medications, and over-the-counter (OTC) medications – and scored using the pMRCI tool.Results: The study evaluated 145 patients (n=80 young-old, n=65 old-old, n=85 ISCM, n=60 NISCM, mean age 73±7 years, 64% men, 81% Caucasian). Mean total pMRCI scores (32.1±14.4, range 3–84) and total medication counts (13.3±4.8, range 2–30) were high for the entire cohort, of which 72% of patients were taking eleven or more total medications. Total and subtype pMRCI scores and medication counts did not differ significantly between the young-old and old-old groups, with the exception of OTC medication pMRCI score (6.2±4 young-old versus 7.8±5.8 old-old, P=0.04). With regard to heart failure etiology, total pMRCI scores and medication counts were significantly higher in patients with ISCM versus NISCM (pMRCI score 34.5±15.2 versus 28.8±12.7, P=0.009; medication count 14.1±4.9 versus 12.2±4.5, P=0.008), which was largely driven by other prescription medications.Conclusion: Medication regimen complexity is high in older adults with heart failure, and differs based on heart failure etiology. Additional work is needed to address polypharmacy and to determine if medication regimen complexity influences adherence and clinical outcomes in this population. Keywords: medication complexity, heart failure, elderly, geriatric, agedhttps://www.dovepress.com/medication-regimen-complexity-in-ambulatory-older-adults-with-heart-fa-peer-reviewed-article-CIAmedication complexityheart failureelderlygeriatricaged
spellingShingle Cobretti MR
Page RL 2nd
Linnebur SA
Deininger KM
Ambardekar AV
Lindenfeld J
Aquilante CL
Medication regimen complexity in ambulatory older adults with heart failure
Clinical Interventions in Aging
medication complexity
heart failure
elderly
geriatric
aged
title Medication regimen complexity in ambulatory older adults with heart failure
title_full Medication regimen complexity in ambulatory older adults with heart failure
title_fullStr Medication regimen complexity in ambulatory older adults with heart failure
title_full_unstemmed Medication regimen complexity in ambulatory older adults with heart failure
title_short Medication regimen complexity in ambulatory older adults with heart failure
title_sort medication regimen complexity in ambulatory older adults with heart failure
topic medication complexity
heart failure
elderly
geriatric
aged
url https://www.dovepress.com/medication-regimen-complexity-in-ambulatory-older-adults-with-heart-fa-peer-reviewed-article-CIA
work_keys_str_mv AT cobrettimr medicationregimencomplexityinambulatoryolderadultswithheartfailure
AT pagerl2nd medicationregimencomplexityinambulatoryolderadultswithheartfailure
AT linnebursa medicationregimencomplexityinambulatoryolderadultswithheartfailure
AT deiningerkm medicationregimencomplexityinambulatoryolderadultswithheartfailure
AT ambardekarav medicationregimencomplexityinambulatoryolderadultswithheartfailure
AT lindenfeldj medicationregimencomplexityinambulatoryolderadultswithheartfailure
AT aquilantecl medicationregimencomplexityinambulatoryolderadultswithheartfailure